ArticlePloS one2008
Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents.
Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?British journal of clinical pharmacology · 2008Pooled it
- Trial
- Article
- Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine.Clinical medicine (London, England) · 2021Article
- Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study.BMJ open · 2019Article
- "Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.Journal of empirical research on human research ethics : JERHRE · 2018Article
- Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.BMC health services research · 2016Article
- A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks.PloS one · 2015Article
- Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals.World journal of surgery · 2014Article
- Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.PloS one · 2013Article
- Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study.BMC medical ethics · 2012Article
- Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2012Article
- Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse.PloS one · 2012Article
- Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures.PLoS medicine · 2012Article
- Disclosures of funding sources and conflicts of interest in published HIV/AIDS research conducted in developing countries.Journal of medical ethics · 2010Article
- The unbearable lightness of health science reporting: a week examining Italian print media.PloS one · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDisclosure of authors' financial interests has been proposed as a strategy for protecting the integrity of the biomedical literature. We examined whether authors' financial interests were disclosed consistently in articles on coronary stents published in 2006. METHODOLOGY/PRINCIPAL
findingsWe searched PubMed for English-language articles published in 2006 that provided evidence or guidance regarding the use of coronary artery stents. We recorded article characteristics, including information about authors' financial disclosures. The main outcome measures were the prevalence, nature, and consistency of financial disclosures. There were 746 articles, 2985 authors, and 135 journals in the database. Eighty-three percent of the articles did not contain disclosure statements for any author (including declarations of no interests). Only 6% of authors had an article with a disclosure statement. In comparisons between articles by the same author, the types of disagreement were as follows: no disclosure statements vs declarations of no interests (64%); specific disclosures vs no disclosure statements (34%); and specific disclosures vs declarations of no interests (2%). Among the 75 authors who disclosed at least 1 relationship with an organization, there were 2 cases (3%) in which the organization was disclosed in every article the author wrote. CONCLUSIONS/SIGNIFICANCE: In the rare instances when financial interests were disclosed, they were not disclosed consistently, suggesting that there are problems with transparency in an area of the literature that has important implications for patient care. Our findings suggest that the inconsistencies we observed are due to both the policies of journals and the behavior of some authors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.